Hydralazine 20 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26F9Y78
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,649
Award facts
- Contract value 100% obligated
- $7,649.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,649.39 to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/mL vials. The contract, awarded on January 20, 2026, with an ultimate completion date of January 21, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet Defense Logistics Agency procurement requirements through open competition. Hydralazine, an antihypertensive medication, supports the medical supply needs of the Defense Health Agency and other government healthcare systems. The parent company, Cencora, Inc., holds a larger IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, underscoring the significance of the AmerisourceBergen/Cencora partnership in supporting federal pharmaceutical supply chains.
Quick answers
Who was awarded contract SPE2DR26F9Y78?
SPE2DR26F9Y78 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9Y78 worth?
The government has obligated $7,649 on SPE2DR26F9Y78.
Is contract SPE2DR26F9Y78 an order under another contract?
Yes. SPE2DR26F9Y78 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Y78 competed?
The extent of competition for SPE2DR26F9Y78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award